therapeutic 1,369 words KG: ent-gene-662a6a23 2026-03-23
kind:therapeuticsection:therapeuticsstate:published
Contents

SIRT2 Modulation Therapy

🔬 Protein Info
Gene Symbolent-gene-662a6a23
TargetSIRT2 (NAD+-dependent deacetylase)
MechanismInhibition
Drug ClassSmall molecule inhibitor
Development StagePreclinical to Phase I
ConditionsParkinson's Disease, Alzheimer's Disease, Huntington's Disease
KG Connections2 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65

Related Analyses (25)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Related Experiments (3)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Sirtuin Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40

Knowledge Graph (2 edges)

ent-gene-662a6a23 data_in benchmark_ot_ad_answer_key:SIRT2
benchmark_ot_ad_answer_key:SIRT2 data_in ent-gene-662a6a23